Fatemeh Yaghoobi

Fatemeh Yaghoobi

Auto-generated profile, based on publicly available information

Fatemeh Yaghoobi

Department of Pathology, Babol Branch, Bab.C, Islamic Azad University, Babol, Iran

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 December 2025 in International Wound Journal
Verified
Journal Article
Open access
SHSeyedeh-Sara Hashemi
Seyedeh-Sara Hashemi
ARAlireza Rafati
Alireza Rafati
SRShahin Roohinejad
Shahin Roohinejad
FYFatemeh Yaghoobi
Fatemeh Yaghoobi
ASAlireza Salehi
Alireza Salehi
Postbiotics, non‐viable microbial components or metabolites derived from probiotics, represent a promising new class of therapeutic agents in dermatological and wound‐healing science. This review highlights the bioactive potential of postbiotics in modulating inflammation, enhancing tissue regeneration, and restoring microbiota balance in skin wounds. Through analysis of recent experimental and clinical studies, postbiotics were found to accelerate wound closure, stimulate collagen synthesis, and improve barrier integrity while providing antimicrobial and immunomodulatory benefits. Their incorporation into topical formulations and wound dressings has shown to regulate moisture, prevent infection, and support optimal healing conditions. In contrast to live probiotics, postbiotics are stable, safe, and free from viability‐related limitations, making them ideal for cosmetic and medical use. Overall, postbiotics represent an innovative, next‐generation strategy for skin regeneration and wound management.

6 April 2026 in Scientific Reports
Verified
Journal Article
Open access
PDF file
ASAlireza Salehi
Alireza Salehi
FYFatemeh Yaghoobi
Fatemeh Yaghoobi
SHSeyed Mohammad Hosseini
Seyed Mohammad Hosseini
SHSeyedeh-Sara Hashemi
Seyedeh-Sara Hashemi
7,12-Dimethylbenz[a]anthracene (DMBA) induces reactive oxygen species (ROS) formation, oxidative stress, and apoptosis in target tissues. Royal jelly (RJ) is rich in flavonoids, phenolic acids, and peptides. This study evaluated whether RJ can mitigate DMBA-induced oxidative, apoptotic, and histopathological changes in the rat mammary gland and skin. Female Wistar rats were divided into four groups, including the Control (no treatment), RJ (300 mg/kg/week, orally), DMBA (single dose 80 mg/kg, IP), and DMBA + RJ (same doses). After 8 weeks, mammary gland and skin specimens were collected. Oxidative stress markers were quantified in tissue homogenates. Apoptotic gene and protein expression were measured by qRT-PCR and Western blot, respectively. Ki67 expression was assessed by immunohistochemistry. Additionally, histopathological evaluation (H&E stain) was conducted. DMBA significantly increased MDA, reduced GPx, SOD, and TAC. Pro-apoptotic markers were upregulated, while Bcl2 was downregulated. Histopathology revealed vacuolar degeneration, necrosis, mitotic figures, and corpora amylacea in the mammary gland, and epidermal hyperplasia, mitotic figures, follicular hyperplasia, and focal necrosis in skin. RJ co-treatment restored GPx and SOD levels to almost those of the control group, reduced MDA, decreased p53 and Bax to near-control levels, and increased Bcl2 to the approximate level of the control group. Moreover, RJ treatment normalized the mammary gland histologically, while skin showed attenuated necrosis and decreased epidermal hyperplasia and mitotic index. RJ effectively countered DMBA-induced oxidative stress and apoptosis in the rat mammary gland while preserving tissue integrity. In skin, RJ mitigated oxidative damage and reduced proliferation. These outcomes suggest RJ’s potential as an adjuvant antioxidant in glandular disorders, while showing the anticarcinogenic potential.

28 September 2025 in Clinical Case Reports
Verified
Journal Article
Open access
MZMasoumeh Zaree
Masoumeh Zaree
BJBahia Namavar Jahromi
Bahia Namavar Jahromi
MPMohammad Ebrahim Parsanezhad
Mohammad Ebrahim Parsanezhad
ZMZahra Mosallanezhad
Zahra Mosallanezhad
SHSeyedeh-Sara Hashemi
Seyedeh-Sara Hashemi
ASAlireza Salehi
Alireza Salehi
Endometrial thickness (ET) is an important parameter of determining endometrial receptivity for in vitro fertilization (IVF) with frozen–thawed embryo transfer (FET). ET is influenced by various intrinsic and extrinsic factors, such as hormonal fluctuations, age‐related changes, underlying medical conditions, and metabolic factors. However, there are few published studies examining the effect of tamoxifen on endometrial development during IVF. The aim of this study was to evaluate the impact of tamoxifen on endometrial growth in patients undergoing IVF‐FET who experienced a thin endometrium during their previous transfer cycle while undergoing estrogen therapy. This pilot study was conducted at Hazrate Zeinab Hospital, affiliated to Shiraz University of Medical Sciences in Shiraz, Iran, between 2019 and 2021. The study involved three infertile females aged 31–40 years who were referred to our center for IVF‐FET. We recorded the patients' demographic and medical characteristics, the type of infertility, and the cause and duration of infertility. ET was measured using ultrasonography before the treatment began. Patients were then administered tamoxifen at a dosage of 20 mg per day, starting on the second day of their menstrual cycle for a duration of 5 days. On the seventh day of menstruation, a follow‐up transvaginal ultrasonography was performed to assess the ET and evaluate the trilinear pattern. In our study of three patients with a history of inadequate response to high‐dose estrogen, the endometrium improved in two patients and thickened by up to 7 mm, indicating a positive effect of tamoxifen on improving endometrial thickness.